These data illustrate that ZEB1/2 and miR-200s are not just functional rivals during cellular differentiation (EMT) and dedifferentiation (MET) processes in cancer, but mutually control the expression of each other, generating a double-negative feedback loop [136]. The gene discussed is ZEB1; the disease is cancer.